Neuropsychological assessments, raw scores I & II. Data displayed as raw scores for each patient on each assessment, at baseline and follow-up. Greyed scores represent impairment based on normalised scores thresholds. CW = colour-word; RMW/RMF = Recognition Memory Test, Words/Faces. ~ means data missing. (PDF 63 kb
Voxel-based morphometric analysis of global atrophy in the dementia with Lewy bodies group or the Al...
Table S1. Incidental findings on MRI. Table S2. Effect of amyloid on longitudinal MRI measures in co...
Table S1. Sample List. AD, Alzheimer’s disease; AS, asymptomatic Alzheimer’s disease; CT, control; M...
Description of the neuropsychological data of the CCC and ADNI sample (M ± SD: mean ± standard devia...
Table S1. Exclusion criteria in the National Alzheimer’s Coordination Center Neuropathology Form. Ta...
Showing partial correlations between the normalized behavioural scores and the normalized volumes of...
Description of neuropsychological battery. Here is the description of neuropsychological assessments...
Subgroup meta-analysis of studies using 3.0Â T MRI scanners (Nâ=â9). Abbreviations: N, number of...
Table S1. Sociodemographic, genetic, and mood descriptive data in the MRI sample. Table S2. Frequenc...
Showing group analyses: local GM loss in group A1 S2.a and group B1 S2.b as compared with group C1 a...
Table S1. Description of the cognitive tests used in this study based on the CANTAB user manual. Tec...
Supplement 1. Additional information on neuropsychological tests. Supplement 2. - Additional informa...
Figure S1. Grey matter volume reduction in the Alzheimer’s disease group (n = 39) compared to health...
Table S2. Mean values and standard errors for MS group scores on RTI, RVP, and PAL reassessment, 6–9...
Compiled values for all biomarkers measured in the plasma of aMCI vs NC subjects. Data for the measu...
Voxel-based morphometric analysis of global atrophy in the dementia with Lewy bodies group or the Al...
Table S1. Incidental findings on MRI. Table S2. Effect of amyloid on longitudinal MRI measures in co...
Table S1. Sample List. AD, Alzheimer’s disease; AS, asymptomatic Alzheimer’s disease; CT, control; M...
Description of the neuropsychological data of the CCC and ADNI sample (M ± SD: mean ± standard devia...
Table S1. Exclusion criteria in the National Alzheimer’s Coordination Center Neuropathology Form. Ta...
Showing partial correlations between the normalized behavioural scores and the normalized volumes of...
Description of neuropsychological battery. Here is the description of neuropsychological assessments...
Subgroup meta-analysis of studies using 3.0Â T MRI scanners (Nâ=â9). Abbreviations: N, number of...
Table S1. Sociodemographic, genetic, and mood descriptive data in the MRI sample. Table S2. Frequenc...
Showing group analyses: local GM loss in group A1 S2.a and group B1 S2.b as compared with group C1 a...
Table S1. Description of the cognitive tests used in this study based on the CANTAB user manual. Tec...
Supplement 1. Additional information on neuropsychological tests. Supplement 2. - Additional informa...
Figure S1. Grey matter volume reduction in the Alzheimer’s disease group (n = 39) compared to health...
Table S2. Mean values and standard errors for MS group scores on RTI, RVP, and PAL reassessment, 6–9...
Compiled values for all biomarkers measured in the plasma of aMCI vs NC subjects. Data for the measu...
Voxel-based morphometric analysis of global atrophy in the dementia with Lewy bodies group or the Al...
Table S1. Incidental findings on MRI. Table S2. Effect of amyloid on longitudinal MRI measures in co...
Table S1. Sample List. AD, Alzheimer’s disease; AS, asymptomatic Alzheimer’s disease; CT, control; M...